Pharmacy Research Reports Volume 5 Special Issue (December 2022)
Ivermectin for the Treatment of COVID-19 Infection
A Technical Report by
The Drug Expert Task Force for Ivermectin (DETF-ivermectin) Pharmaceutical Services Programme, Ministry of Health Malaysia
(Dr Abdul Haniff bin Mohamad Yahaya, Rohana binti Hassan, Dr. Nur Sufiza binti Ahmad, Dr. Rahela binti Ambaras Khan, Dr. Jannatul Ain binti Jamal, Suhailah binti Abu Bakar, Dr. Zaril Harza bin Zakaria, Rosliza binti Lajis, Dr. Vidhya Hariraj, Dr. Rosliana binti Rosli, Salina binti Mohd Zamani, Abdul Halim bin Abu Naim, Aiza Adlina binti Abdullah, Zeti Hulwani binti Baba, Azri bin Nasruddin, Lee Sing Chet, Azlina binti Ismail, Siti Nurul Fathihah binti Baharuddin, Chan Pui Lim, Noor Azmina binti Mat Daud, Dr. Noraini binti Nordin)
In August 2021, the Drug Expert Task Force for Ivermectin (DETF-ivermectin) was established by the Pharmaceutical Services Programme, MOH to provide recommendations to the policymakers regarding the use of ivermectin for COVID-19 treatment. A technical report was prepared by the DETF-ivermectin to summarise the evidence related to ivermectin’s use in COVID-19. The technical report was published as a special issue of Pharmacy Research Reports Volume 5 2022.